Barclays initiating coverage with an overweight rating and an 85% upside target signals strong institutional confidence in Ethos Technologies, potentially attracting significant investor interest. This analysis highlights the stock's current undervaluation compared to industry peers, suggesting a major re-rating opportunity if the market adjusts its valuation approach.
Context & Background
Ethos Technologies stock trades at $10.80, well below Barclays' $20 target
The company has a market cap of $675.6 million and trades at a discount to insurance brokers
The stock has declined 35.9% over the past six months, potentially offering an entry point
What Happens Next
Investors will receive updated company guidance with earnings scheduled in just two days, which will test Barclays' positive thesis. The market will watch to see if other analysts follow Barclays' and Baird's lead with similarly bullish ratings.
Frequently Asked Questions
What is Barclays' price target for Ethos Technologies?
Barclays has set a price target of $20.00 for Ethos Technologies stock.
Why does Barclays believe the stock is undervalued?
Barclays notes the stock trades at roughly 6x EBITDA, a sharp discount to insurance broker peers.
What is the Rule of 40% mentioned in the analysis?
The Rule of 40% is a metric used to assess tech company health, balancing growth and profitability; Barclays noted Ethos operates above this threshold.
}
Original Source
try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Gold prices extend gains on fresh Trump tariff jitters Can gold rise to new highs above $5,600 in 2026? Bitcoin slips after earlier gains amid tariff volatility Bull vs. bear argument on Friday’s Supreme Court tariff ruling (South Africa Philippines Nigeria) Barclays initiates Ethos Technologies stock at overweight, $20 target By Investing.com Analyst Ratings Published 02/23/2026, 02:49 AM Barclays initiates Ethos Technologies stock at overweight, $20 target 0 LIFE -0.83% Investing.com - Barclays initiated coverage on Ethos Technologies (NASDAQ:LIFE) with an overweight rating and a price target of $20.00. The stock currently trades at $10.80, representing an 85% upside to the analyst’s target. InvestingPro analysis suggests the stock is undervalued, with shares trading below the platform’s Fair Value estimate. The firm noted that Ethos Technologies trades at roughly 6x EBITDA, representing a sharp discount to insurance broker peers and closer to lead-generation peers. Current data shows an EV/EBITDA multiple of 13.82 for the company’s $675.6 million market cap. Barclays said the stock offers investors the opportunity for both estimate revision upwards and multiple expansion if the market begins to value the company like its brokerage peers. An InvestingPro tip notes the stock has taken a big hit over the last six months, declining 35.9%, which may present an entry opportunity for investors. Barclays highlighted four factors supporting its positive view. The firm said Ethos operates in a large total addressable market, with nearly 10 million people purchasing life insurance each year in the United States. The company has built a deep technology stack while remaining asset light from an insurance perspective, not taking on balance sheet risk. Ethos has a track record of launching new products that expand into new revenue areas, according to Barclays. The firm also noted the company is operating above the Rule o...
